Participant characteristics (n=325) | Mean±SD |
---|---|
Mean max bilateral CIMT, mm | 1.0±0.3 |
Max CIMT, mm | 2.0±0.9 |
Age, y | 60.3±8.7 |
Sex, female/male | 142/183 |
Estimated diabetes duration, y | 8.2±6.1 |
Body weight, kg | 84.3±18.2 |
BMI, kg/m2 | 30.3±5.7 |
Waist circumference, cm* | 104.7±13.5 |
Waist:hip ratio | 1.0±0.1 |
Systolic blood pressure, mm Hg | 122.2±11.2 |
Diastolic blood pressure, mm Hg | 71.6±8.2 |
Mean arterial pressure, mm Hg | 88.5±8.2 |
Pulse, bpm | 71.9±9.6 |
Pulse pressure, mm Hg | 50.8±10.0 |
Fasting glucose, mmol/L | 7.5±1.5 |
HbA1c, % | 7.1±0.5 |
Total-C mmol/L | 4.0±1.0 |
HDL-C mmol/L | 1.2±0.3 |
LDL-C mmol/L | 2.2±0.8 |
Serum triglycerides, mmol/L | 1.5±0.9 |
Total:HDL-C ratio | 3.6±1.0 |
Non-HDL-C, mmol/L | 2.9±0.9 |
CVD risk, FRS | 19.5±11.3 |
Previous CVD event, % | 4.6 |
Smoking | |
Non-smoker, % | 84.6 |
Former, % | 10.2 |
Current, % | 5.2 |
Diabetes meds—sulfonylurea or TZD % | 37.5 |
Cholesterol meds, % | 72.3 |
Blood pressure meds, % | 66.5 |
Ethnicity, % | |
African | 6.8 |
European | 32.3 |
Far Eastern | 8.9 |
Hispanic | 1.9 |
Indian/South Asian | 22.8 |
Other Caucasian | 19.7 |
Other | 20.0 |
*Measured at the umbilicus.
BMI, body mass index; bmp, beats per minute; CIMT, carotid intima media thickness; CVD, cardiovascular disease; FRS, Framingham Risk Score; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; meds, medication use; Total-C, total cholesterol; TZD, thiazolidinediones; y, years.